sr141716 has been researched along with methoxyamine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bergström, MA; Castagnoli, N; Isin, EM; Milne, CE | 1 |
1 other study(ies) available for sr141716 and methoxyamine
Article | Year |
---|---|
Bioactivation pathways of the cannabinoid receptor 1 antagonist rimonabant.
Topics: Animals; Biotransformation; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Humans; Hydroxylamines; Microsomes, Liver; Oxidation-Reduction; Piperidines; Potassium Cyanide; Protein Binding; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Rimonabant | 2011 |